Cargando…

Heterogeneous network propagation with forward similarity integration to enhance drug–target association prediction

Identification of drug–target interaction (DTI) is a crucial step to reduce time and cost in the drug discovery and development process. Since various biological data are publicly available, DTIs have been identified computationally. To predict DTIs, most existing methods focus on a single similarit...

Descripción completa

Detalles Bibliográficos
Autores principales: Tangmanussukum, Piyanut, Kawichai, Thitipong, Suratanee, Apichat, Plaimas, Kitiporn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575853/
https://www.ncbi.nlm.nih.gov/pubmed/36262151
http://dx.doi.org/10.7717/peerj-cs.1124
_version_ 1784811403272519680
author Tangmanussukum, Piyanut
Kawichai, Thitipong
Suratanee, Apichat
Plaimas, Kitiporn
author_facet Tangmanussukum, Piyanut
Kawichai, Thitipong
Suratanee, Apichat
Plaimas, Kitiporn
author_sort Tangmanussukum, Piyanut
collection PubMed
description Identification of drug–target interaction (DTI) is a crucial step to reduce time and cost in the drug discovery and development process. Since various biological data are publicly available, DTIs have been identified computationally. To predict DTIs, most existing methods focus on a single similarity measure of drugs and target proteins, whereas some recent methods integrate a particular set of drug and target similarity measures by a single integration function. Therefore, many DTIs are still missing. In this study, we propose heterogeneous network propagation with the forward similarity integration (FSI) algorithm, which systematically selects the optimal integration of multiple similarity measures of drugs and target proteins. Seven drug–drug and nine target–target similarity measures are applied with four distinct integration methods to finally create an optimal heterogeneous network model. Consequently, the optimal model uses the target similarity based on protein sequences and the fused drug similarity, which combines the similarity measures based on chemical structures, the Jaccard scores of drug–disease associations, and the cosine scores of drug–drug interactions. With an accuracy of 99.8%, this model significantly outperforms others that utilize different similarity measures of drugs and target proteins. In addition, the validation of the DTI predictions of this model demonstrates the ability of our method to discover missing potential DTIs.
format Online
Article
Text
id pubmed-9575853
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-95758532022-10-18 Heterogeneous network propagation with forward similarity integration to enhance drug–target association prediction Tangmanussukum, Piyanut Kawichai, Thitipong Suratanee, Apichat Plaimas, Kitiporn PeerJ Comput Sci Bioinformatics Identification of drug–target interaction (DTI) is a crucial step to reduce time and cost in the drug discovery and development process. Since various biological data are publicly available, DTIs have been identified computationally. To predict DTIs, most existing methods focus on a single similarity measure of drugs and target proteins, whereas some recent methods integrate a particular set of drug and target similarity measures by a single integration function. Therefore, many DTIs are still missing. In this study, we propose heterogeneous network propagation with the forward similarity integration (FSI) algorithm, which systematically selects the optimal integration of multiple similarity measures of drugs and target proteins. Seven drug–drug and nine target–target similarity measures are applied with four distinct integration methods to finally create an optimal heterogeneous network model. Consequently, the optimal model uses the target similarity based on protein sequences and the fused drug similarity, which combines the similarity measures based on chemical structures, the Jaccard scores of drug–disease associations, and the cosine scores of drug–drug interactions. With an accuracy of 99.8%, this model significantly outperforms others that utilize different similarity measures of drugs and target proteins. In addition, the validation of the DTI predictions of this model demonstrates the ability of our method to discover missing potential DTIs. PeerJ Inc. 2022-10-11 /pmc/articles/PMC9575853/ /pubmed/36262151 http://dx.doi.org/10.7717/peerj-cs.1124 Text en ©2022 Tangmanussukum et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ Computer Science) and either DOI or URL of the article must be cited.
spellingShingle Bioinformatics
Tangmanussukum, Piyanut
Kawichai, Thitipong
Suratanee, Apichat
Plaimas, Kitiporn
Heterogeneous network propagation with forward similarity integration to enhance drug–target association prediction
title Heterogeneous network propagation with forward similarity integration to enhance drug–target association prediction
title_full Heterogeneous network propagation with forward similarity integration to enhance drug–target association prediction
title_fullStr Heterogeneous network propagation with forward similarity integration to enhance drug–target association prediction
title_full_unstemmed Heterogeneous network propagation with forward similarity integration to enhance drug–target association prediction
title_short Heterogeneous network propagation with forward similarity integration to enhance drug–target association prediction
title_sort heterogeneous network propagation with forward similarity integration to enhance drug–target association prediction
topic Bioinformatics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575853/
https://www.ncbi.nlm.nih.gov/pubmed/36262151
http://dx.doi.org/10.7717/peerj-cs.1124
work_keys_str_mv AT tangmanussukumpiyanut heterogeneousnetworkpropagationwithforwardsimilarityintegrationtoenhancedrugtargetassociationprediction
AT kawichaithitipong heterogeneousnetworkpropagationwithforwardsimilarityintegrationtoenhancedrugtargetassociationprediction
AT surataneeapichat heterogeneousnetworkpropagationwithforwardsimilarityintegrationtoenhancedrugtargetassociationprediction
AT plaimaskitiporn heterogeneousnetworkpropagationwithforwardsimilarityintegrationtoenhancedrugtargetassociationprediction